115 related articles for article (PubMed ID: 7527295)
1. Molecular characterization of prostate-specific antigen messenger RNA expressed in breast tumors.
Monne M; Croce CM; Yu H; Diamandis EP
Cancer Res; 1994 Dec; 54(24):6344-7. PubMed ID: 7527295
[TBL] [Abstract][Full Text] [Related]
2. Detection of hematogenous micrometastasis in patients with prostate cancer.
Moreno JG; Croce CM; Fischer R; Monne M; Vihko P; Mulholland SG; Gomella LG
Cancer Res; 1992 Nov; 52(21):6110-2. PubMed ID: 1382851
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of prostate-specific antigen for women with breast cancer: a large United States cohort study.
Yu H; Levesque MA; Clark GM; Diamandis EP
Clin Cancer Res; 1998 Jun; 4(6):1489-97. PubMed ID: 9626467
[TBL] [Abstract][Full Text] [Related]
4. Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases.
Thiounn N; Saporta F; Flam TA; Pages F; Zerbib M; Vieillefond A; Martin E; Debré B; Chevillard S
Urology; 1997 Aug; 50(2):245-50. PubMed ID: 9255296
[TBL] [Abstract][Full Text] [Related]
5. Prostate specific antigen--new applications in breast and other cancers.
Diamandis EP
Anticancer Res; 1996; 16(6C):3983-4. PubMed ID: 9042323
[TBL] [Abstract][Full Text] [Related]
6. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
Gomella LG; Raj GV; Moreno JG
J Urol; 1997 Aug; 158(2):326-37. PubMed ID: 9224297
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen messenger RNA is expressed in non-prostate cells: implications for detection of micrometastases.
Smith MR; Biggar S; Hussain M
Cancer Res; 1995 Jun; 55(12):2640-4. PubMed ID: 7540108
[TBL] [Abstract][Full Text] [Related]
8. Novel polymorphisms of prostate-specific antigen (PSA) gene associated with PSA mRNA expression in breast cancer.
Yang QF; Sakurai T; Shan L; Yu Z; Yoshimura G; Suzuma T; Tamaki T; Umemura T; Nakamura M; Nakamura Y; Mori I; Kakudo K
J Hum Genet; 2000; 45(6):363-6. PubMed ID: 11185746
[TBL] [Abstract][Full Text] [Related]
9. Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer.
Yu H; Giai M; Diamandis EP; Katsaros D; Sutherland DJ; Levesque MA; Roagna R; Ponzone R; Sismondi P
Cancer Res; 1995 May; 55(10):2104-10. PubMed ID: 7538047
[TBL] [Abstract][Full Text] [Related]
10. The presence of prostate-specific antigen-related genes in primates and the expression of recombinant human prostate-specific antigen in a transfected murine cell line.
Karr JF; Kantor JA; Hand PH; Eggensperger DL; Schlom J
Cancer Res; 1995 Jun; 55(11):2455-62. PubMed ID: 7538903
[TBL] [Abstract][Full Text] [Related]
11. Expression of the prostate-specific antigen gene by a primary ovarian carcinoma.
Yu H; Diamandis EP; Levesque M; Asa SL; Monne M; Croce CM
Cancer Res; 1995 Apr; 55(8):1603-6. PubMed ID: 7536128
[TBL] [Abstract][Full Text] [Related]
12. Prostate specific antigen (PSA) in breast and ovarian cancer.
Kucera E; Kainz C; Tempfer C; Zeillinger R; Koelbl H; Sliutz G
Anticancer Res; 1997; 17(6D):4735-7. PubMed ID: 9494598
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction.
Pinzani P; Lind K; Malentacchi F; Nesi G; Salvianti F; Villari D; Kubista M; Pazzagli M; Orlando C
Hum Pathol; 2008 Oct; 39(10):1474-82. PubMed ID: 18619642
[TBL] [Abstract][Full Text] [Related]
14. Expression profile of prostate-specific antigen messenger RNA assessed by in situ hybridization is a novel prognostic marker for patients with untreated prostate cancer.
Tsurusaki T; Koji T; Sakai H; Kanetake H; Saito Y
Clin Cancer Res; 1998 Sep; 4(9):2187-94. PubMed ID: 9748138
[TBL] [Abstract][Full Text] [Related]
15. Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction.
Deguchi T; Doi T; Ehara H; Ito S; Takahashi Y; Nishino Y; Fujihiro S; Kawamura T; Komeda H; Horie M
Cancer Res; 1993 Nov; 53(22):5350-4. PubMed ID: 7693338
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of prostate-specific antigen (PSA) in prostate cancer cells expressing mutant p53 is associated with tumor metastasis.
Downing S; Bumak C; Nixdorf S; Ow K; Russell P; Jackson P
Mol Carcinog; 2003 Nov; 38(3):130-40. PubMed ID: 14587098
[TBL] [Abstract][Full Text] [Related]
17. [Determination of prostate-specific antigen (PSA) in cytosol of breast tumors and human endometrium--new diagnostic approaches].
Seliger E; Kaltwasser P; Röpke F
Zentralbl Gynakol; 1998; 120(4):172-5. PubMed ID: 9610520
[TBL] [Abstract][Full Text] [Related]
18. Detection of circulating prostate specific antigen expressing prostatic cells in the bone marrow of radical prostatectomy patients by sensitive reverse transcriptase polymerase chain reaction.
Gao CL; Dean RC; Pinto A; Mooneyhan R; Connelly RR; McLeod DG; Srivastava S; Moul JW
J Urol; 1999 Apr; 161(4):1070-6. PubMed ID: 10081840
[TBL] [Abstract][Full Text] [Related]
19. The promoter and the enhancer region of the KLK 3 (prostate specific antigen) gene is frequently mutated in breast tumours and in breast carcinoma cell lines.
Majumdar S; Diamandis EP
Br J Cancer; 1999 Mar; 79(9-10):1594-602. PubMed ID: 10188912
[TBL] [Abstract][Full Text] [Related]
20. Limitations of detection of bone-marrow micrometastasis in prostate carcinoma patients by CK18/PSA immunocytochemistry and PSA RT-PCR.
Albers P; Ko Y; Wardelmann E; Schmidt D; Adam M; Vetter H; Müller SC
Anticancer Res; 2000; 20(3B):2107-11. PubMed ID: 10928161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
